Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Zhejiang Hisun
Welcome,
Profile
Billing
Logout
24 Products
29 Diseases
24 Products
38 Trials
441 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
3
6
9
12
15
18
21
24
27
30
Seebri Breezhaler
(glycopyrronium bromide) / Novartis, Vectura, Nxera Pharma
Anruixi
(zuberitamab) / Zhejiang Hisun
firtecan pegol
(PEG-SN38) / Belrose
HS627
(pertuzumab biosimilar) / Zhejiang Hisun
AnBaiNuo
(etanercept biosimilar) / Zhejiang Hisun
hyzetimibe
(HS-25) / Zhejiang Hisun
sudubrilimab
(HS636) / Zhejiang Hisun
AD-35
/ Zhejiang Hisun
GSK5926371
/ GSK
HS016
(adalimumab biosimilar) / Zhejiang Hisun
HS632
(omalizumab biosimilar) / Zhejiang Hisun
ADC2122
/ ZovaBio, Adcoris
CBLB612
/ Statera BioPharma
HS269
/ Zhejiang Hisun
ansipastobart
(BR101) / Zhejiang Hisun
lumistobart
(BR105) / Zhejiang Hisun
pritumumab
(CLNH 11) / Nascent Biotech
